Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

<jats:title>ABSTRACT</jats:title> <jats:p>Constitutive activation of the Wnt/β-catenin signaling pathway is a notable feature of a large minority of cases of malignant melanoma, an aggressive and increasingly common cancer. The identification of target genes downstream from this pathway is therefore crucial to our understanding of the disease. The POU domain transcription factor Brn-2 has been implicated in control of proliferation and melanoma survival, and its expression is strongly upregulated in melanoma. We show here that in vivo <jats:italic>Brn-2</jats:italic> is expressed in melanocytes but not in embryonic day 11.5 melanoblasts and that its expression is directly controlled by the Wnt/β-catenin signaling pathway in melanoma cell lines and in transgenic mice. Moreover, silent interfering RNA-mediated inhibition of Brn-2 expression in melanoma cells overexpressing β-catenin results in significantly decreased proliferation. These results, together with the observation that BRAF signaling also induces <jats:italic>Brn-2</jats:italic> expression, reveal that <jats:italic>Brn-2</jats:italic> is a focus for the convergence of two key melanoma-associated signaling pathways that are linked to cell proliferation.</jats:p>

Original publication

DOI

10.1128/mcb.24.7.2915-2922.2004

Type

Journal article

Journal

Molecular and Cellular Biology

Publisher

American Society for Microbiology

Publication Date

01/04/2004

Volume

24

Pages

2915 - 2922